Literature DB >> 9143314

Immunosenescence in HIV pathogenesis.

J P Pommier1, L Gauthier, J Livartowski, P Galanaud, F Boué, A Dulioust, D Marcé, C Ducray, L Sabatier, J Lebeau, F D Boussin.   

Abstract

Telomeres are complex protein-DNA structures located at the ends of eukaryotic chromosomes. In a normal cell, telomere DNA shortens with cell divisions. Such a telomere loss may act as a mitotic clock to eventually signal cell cycling exit and cellular senescence. In a transversal study, we found a marked decrease in telomere length of peripheral blood mononuclear cells in HIV-infected patients with advanced immunodeficiency. This telomere reduction concerns T4, T8, and B lymphocytes, providing evidence of high turnover of these cells in the course of HIV infection. These data suggest that replicative senescence could be involved in the final immunosuppression and may have important therapeutical implications.

Entities:  

Mesh:

Year:  1997        PMID: 9143314     DOI: 10.1006/viro.1997.8512

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2.

Authors:  Katia Ancelin; Michele Brunori; Serge Bauwens; Catherine-Elaine Koering; Christine Brun; Michelle Ricoul; Jean-Patrick Pommier; Laure Sabatier; Eric Gilson
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

2.  Immunopathologic changes in the thymus during the acute stage of experimentally induced feline immunodeficiency virus infection in juvenile cats.

Authors:  J C Woo; G A Dean; N C Pedersen; P F Moore
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection.

Authors:  Patrick Unemori; Kieron S Leslie; Peter W Hunt; Elizabeth Sinclair; Lorrie Epling; Ronald Mitsuyasu; Rita B Effros; Jeffrey Dock; Sheila G Dollard; Steven G Deeks; Jeffrey N Martin; Toby A Maurer
Journal:  AIDS       Date:  2013-07-17       Impact factor: 4.177

4.  Early life infection, but not breastfeeding, predicts adult blood telomere lengths in the Philippines.

Authors:  Dan T A Eisenberg; Judith B Borja; M Geoffrey Hayes; Christopher W Kuzawa
Journal:  Am J Hum Biol       Date:  2017-01-25       Impact factor: 1.937

5.  Proliferation and telomere length in acutely mobilized blood mononuclear cells in HIV infected patients.

Authors:  S R Søndergaard; M V Essen; P Schjerling; H Ullum; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

Review 6.  B cell function and influenza vaccine responses in healthy aging and disease.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Curr Opin Immunol       Date:  2014-06-14       Impact factor: 7.486

7.  Telomere length is associated with sleep duration but not sleep quality in adults with human immunodeficiency virus.

Authors:  Kathryn A Lee; Caryl Gay; Janice Humphreys; Carmen J Portillo; Clive R Pullinger; Bradley E Aouizerat
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

8.  Soluble CD163 is associated with shortened telomere length in HIV-infected patients.

Authors:  Suman Srinivasa; Kathleen V Fitch; Eva Petrow; Tricia H Burdo; Kenneth C Williams; Janet Lo; Hélène C F Cȏté; Steven K Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

Review 9.  Assessing immune aging in HIV-infected patients.

Authors:  Victor Appay; Delphine Sauce
Journal:  Virulence       Date:  2016-06-16       Impact factor: 5.882

10.  The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment.

Authors:  Tammy M Rickabaugh; Ryan D Kilpatrick; Lance E Hultin; Patricia M Hultin; Mary Ann Hausner; Catherine A Sugar; Keri N Althoff; Joseph B Margolick; Charles R Rinaldo; Roger Detels; John Phair; Rita B Effros; Beth D Jamieson
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.